# International Journal of Gynecological Cancer

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/international-journal-of-gynecological-cancer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 191,295 |
| h-index | 124 |
| Homepage | https://ijgc.bmj.com |
| Open Access | false |
| ISSN-L | 1048-891X |
| ISSNs | 1048-891X,1525-1438 |
| OpenAlex ID | https://openalex.org/S41026820 |
| Publisher | BMJ |
| Works | 23,809 |

## Journal papers

Showing 12 of 40.

- [ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma](https://scholariq.org/papers/esgo-estro-esp-guidelines-for-the-management-of-patients-with-endometrial/)
- [ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer](https://scholariq.org/papers/esmo-esgo-estro-consensus-conference-on-endometrial-cancer/)
- [The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer](https://scholariq.org/papers/the-european-society-of-gynaecological-oncology-european-society-for-3/)
- [ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*](https://scholariq.org/papers/esgo-estro-esp-guidelines-for-the-management-of-patients-with-cervical-cancer/)
- [SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer](https://scholariq.org/papers/succor-study-an-international-european-cohort-observational-study-comparing/)
- [Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer](https://scholariq.org/papers/prospective-validation-study-of-a-predictive-score-for-operability-of-recurrent/)
- [European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023](https://scholariq.org/papers/european-society-of-gynaecological-oncology-guidelines-for-the-management-of-2/)
- [European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer](https://scholariq.org/papers/european-society-of-gynaecological-oncology-guidelines-for-the-management-of/)
- [TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)](https://scholariq.org/papers/trust-trial-of-radical-upfront-surgical-therapy-in-advanced-ovarian-cancer-engot/)
- [Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective](https://scholariq.org/papers/decrease-in-gynecological-cancer-diagnoses-during-the-covid-19-pandemic-an/)
- [The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience](https://scholariq.org/papers/the-performance-of-magnetic-resonance-imaging-in-early-cervical-carcinoma-a-long/)
- [Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study](https://scholariq.org/papers/low-response-rate-of-second-line-chemotherapy-for-recurrent-or-refractory-clear/)

## Journal top topics

Showing 8 of 25.

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [Endometriosis Research and Treatment](https://scholariq.org/topics/endometriosis-research-and-treatment/)
- [Gynecological conditions and treatments](https://scholariq.org/topics/gynecological-conditions-and-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.